Trademark Search  /  OCELLOS

OCELLOS

○ Dead · Abandoned

U.S. federal trademark · Serial No. 98304980

Mark
OCELLOS
Status
Abandoned
Serial Number
98304980
Filing Date
July 20, 2023
Class(es)
Class 009, Class 041, Class 042, Class 045

Owners

TrakCel Limited
99 · Cardiff, GB
TrakCel Limited
99 · Cardiff, GB

Goods & Services

Downloadable software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Downloadable software for use in managing data for clinical trials; Downloadable software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Downloadable software for use in drug therapy development; Downloadable software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Downloadable software for the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Downloadable software for use in cell and gene therapy orchestration; Downloadable software for use in inventory management for scheduling and planning pharmaceutical resources; Downloadable software for use in control and tracking of cell and gene therapy products

Arranging and conducting of training courses in the field of cell and gene therapy; Arranging and conducting of training workshops in the field of operation and development of software systems; Arranging and conducting of training workshops in the field of cell and gene therapy; Training services in the field of cell and gene therapy

Platform as a service (PAAS) featuring computer software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Platform as a service (PAAS) featuring computer software platforms for use in managing data for clinical trials; Platform as a service (PAAS) featuring computer software platforms for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Platform as a service (PAAS) featuring computer software platforms for use in drug therapy development; Platform as a service (PAAS) featuring computer software platforms for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in cell and gene therapy orchestration; Platform as a service (PAAS) featuring computer software platforms for use in inventory management for scheduling and planning pharmaceutical resources; Platform as a service (PAAS) featuring computer software platforms for use in control and tracking of cell and gene therapy products; Software as a service (SAAS) services featuring software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Software as a service (SAAS) services featuring software for use in managing data for clinical trials; Software as a service (SAAS) services featuring software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Software as a service (SAAS) services featuring software for use in drug therapy development; Software as a service (SAAS) services featuring software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Software as a service (SAAS) services featuring software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Software as a service (SAAS) services featuring software for use in cell and gene therapy orchestration; Software as a service (SAAS) services featuring software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Software as a service (SAAS) services featuring software for use in control and tracking of cell and gene therapy products; Providing temporary use of non-downloadable cloud-based software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Providing temporary use of non-downloadable cloud-based software for use in managing data for clinical trials; Providing temporary use of non-downloadable cloud-based software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Providing temporary use of non-downloadable cloud-based software for use in drug therapy development; Providing temporary use of non-downloadable cloud-based software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in cell and gene therapy orchestration; Providing temporary use of non-downloadable cloud-based software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Providing temporary use of non-downloadable cloud-based software for use in control and tracking of cell and gene therapy products

Licensing of intellectual property in the field of cell and gene therapy; Software licensing; Granting of software licences

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "OCELLOS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.